Showing 2231-2240 of 7391 results for "".
Intergenerational Dermatology: Three Generations of Dermatologists Reflect on the Field
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatology-three-generations-of-dermatologists-reflect-on-the-field/23992/With Sorrel S. Resnik, MD, Barry Resnik, MD, and Sydney Resnik, MD, by Heidi SpleteOne on One with SDPA’s New President
https://practicaldermatology.com/series/sdpa-corner/one-on-one-with-sdpas-new-president/23770/Lauren Miller, MPAS, PA-C has begun her term as president of the SDPA Board of Directors.Winning Combinations in Scar Revision
https://practicaldermatology.com/conferences/asds-2021/winning-combinations-in-scar-revision/20028/Sherrif F. Ibrahim, MD, PhD says a combination approach is often best when it comes to laser scar revision. He discusses the devices he uses to improve the color and texture of scars to meet his patients' needs.Liquid Rhinoplasty and Beyond: Injectable Pearls
https://practicaldermatology.com/series/scientifically-speaking/liquid-rhinoplasty-and-beyond-injectable-pearls/20008/From the best approach to safe and effective liquid nose corrections to tips for enhancing outcomes and streamline operations, Michael Somenek, MD; Kay Durairaj, MD; Shino Bay Aguilera, DO; and Corey Hartman, MD share their best tips with host Joel L. Cohen, MD.Weighing the Evidence: COVID Shots and the Skin
https://practicaldermatology.com/topics/practice-management/weighing-the-evidence-covid-shots-and-the-skin/23576/Cosmetic Surgery Forum faculty members sound off on skin reactions after COVID-19 vaccination.Initiating Biologics
https://practicaldermatology.com/topics/psoriasis/initiating-biologics/19986/Kara S. Gooding, MMS, PA-C offers an overview of a panel discussion about initiating treatment with biologics. The panel shared real-world applications, plus tips on lab monitoring, managing side effects, and choosing the right biologic.An Exciting Year in Dermatology
https://practicaldermatology.com/topics/psoriasis/an-exciting-year-in-dermatology/19929/From new topicals to novel systemic agents, several treatments may be coming to the market in the next two years, while existing therapies may see label expansions. Bruce Strober, MD, PhD offers a look at new MOAs and the evidence for their use.Checkpoint Blockade for Advanced cSCC: Exploring Newer Options
https://practicaldermatology.com/topics/skin-cancer-photoprotection/checkpoint-blockade-for-advanced-cscc-exploring-newer-options/23487/Two newer systemic options on the market provide hope in the fight against advanced cutaneous squamous cell carcinoma.Catch The Wave Of The Future
https://practicaldermatology.com/topics/practice-management/catch-the-wave-of-the-future/23478/Clearwave’s patient engagement platform may help create zero-contact offices.DermWireTV: AAD's Diversity Plan, Galderma Acne Data, Nutrafol Pro-Strength Boosters
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-aads-diversity-plan-galderma-acne-data-nutrafol-pro-strength-boosters/19903/Kanya Ferguson, MD, FAAD, Chair of the AAD’s Diversity Committee, speaks about the AAD’s new comprehensive, three-year plan focused on Diversity, Equity, and Inclusion. It was approved with unanimous support by the AAD’s Board of Directors. A new survey conducted by Galderma and retinoid brand Aklie